MassARRAY® SARS-CoV-2 Panel

High Throughput, Low Cost SARS-CoV-2 Detection

Increasing laboratory efficiency with scalable solutions

United States: For in vitro diagnostic use – FDA Emergency Use Authorization (EUA).
Europe: CE-IVD marked and intended for in vitro diagnostic use in Europe.

The MassARRAY® SARS-CoV-2 Panel from Agena Bioscience® enables laboratories to meet the demands of the COVID-19 pandemic with a high-throughput and low-cost assay for the detection of the novel coronavirus, SARS-CoV-2.

The MassARRAY SARS-CoV-2 Panel is now available, with:

  • ACCURATE DETECTION: Five SARS-CoV-2 assays multiplexed into a single reaction, targeting the nucleocapsid (N) gene and ORF1ab region.
  • SCALABLE THROUGHPUT: Process up to thousands of samples per day with a single instrument.
  • LOW COST: Low-cost reagents and automated results reporting saves lab resources.
  • RELIABLE SUPPLY: Overcome instrument and reagent shortages with a reliable supply.
Panel Resources
Ordering Information
Product # of Samples Format Catalog #
MassARRAY SARS-CoV-2 Panel Set – CPM (10x96) 960 CPM-96 13279F
MassARRAY SARS-CoV-2 Panel Set – CPM (2x384) 768 CPM-384 13278D
MassARRAY SARS-CoV-2 Panel Set – CPM (10x384) 3840 CPM-384 13281D

"This novel method is very sensitive, capable of detecting minute amounts of the virus in samples obtained by nasal swab."

-Yongbao Wang, PhD

Senior Director of Strategic Innovation, the Advanced Diagnostic Laboratories, National Jewish Health